Matthew B. Klein insider trades

Open-market stock purchases and sales by Matthew B. Klein, CHIEF EXECUTIVE OFFICER at PTC Therapeutics, Inc, from SEC Form 4 filings since Apr 16, 2020.

Recent trades

DateStockTradeValue
Aug 4, 2026PTCT PTC Therapeutics, IncSold$706K
May 21, 2026CLPT ClearPoint Neuro, IncSold$185K
May 21, 2026CLPT ClearPoint Neuro, IncBought (not open market)—
May 19, 2026CLPT ClearPoint Neuro, IncBought (not open market)—
May 14, 2026PTCT PTC Therapeutics, IncSold$49.6K
May 14, 2026PTCT PTC Therapeutics, IncSold$528K
May 14, 2026PTCT PTC Therapeutics, IncSold$153K
May 14, 2026PTCT PTC Therapeutics, IncSold$186K
May 13, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Apr 21, 2026PTCT PTC Therapeutics, IncSold$202K
Mar 12, 2026PTCT PTC Therapeutics, IncSold$171K
Mar 11, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Feb 18, 2026PTCT PTC Therapeutics, IncSold$511K
Jan 8, 2026PTCT PTC Therapeutics, IncSold$192K
Jan 7, 2026PTCT PTC Therapeutics, IncSold$234K
Jan 6, 2026PTCT PTC Therapeutics, IncSold$396K
Jan 2, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Jan 2, 2026PTCT PTC Therapeutics, IncBought (not open market)—
Dec 30, 2025PTCT PTC Therapeutics, IncSold$620K
Dec 2, 2025PTCT PTC Therapeutics, IncSold$271K
Dec 1, 2025PTCT PTC Therapeutics, IncBought (not open market)—

Companies traded

  • PTCT PTC Therapeutics, Inc: 38 sales, last Aug 4, 2026
  • CLPT ClearPoint Neuro, Inc: 1 sale, last May 21, 2026

Get free alerts when Matthew B. Klein files a new trade →